CBIO
Crescent Biopharma, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Crescent Biopharma (CBIO) Stock: Buy, Sell, or Hold?
$15.01
+0.25 (+1.73%)
▲
5d:
+16.0%
30d:
+19.32%
90d:
-12.43%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
41/100
Position
EXTENDED
30-Day Fair Range
$12.68 – $14.19
Position: EXTENDED
Forward P/E & Valuation
-5.6x
Next 12M consensus est.
Wall Street Target
$31.50
+113.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.68 / $15.12
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CBIO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CBIO is currently trading at $15.01, which is considered extended relative to its 30-day fair value range of $12.68 to $14.19.
Technical Outlook: Technically, CBIO is in a downtrend. The price is approaching resistance at $15.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CBIO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.50 (+113.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBIO is in a downtrend. The price is approaching resistance at $15.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CBIO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.50 (+113.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.68 -
$14.19
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$12.68 -
$14.19
Current vs Trading Range
EXTENDED
Support Level
$12.68
Resistance Level
$15.12
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+5.8% above its trading range)
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.5% below Wall St target ($31.50)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.61
Wall Street Target
$31.50
(+113.5%)
Share CBIO Analysis
Share this live CBIO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CBIO)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 16, 2026
Daily AI digest
AI Retail Discussion Summary:
Crescent Biopharma announced clinical pipeline momentum, including enrolling patients in CR-001 chemotherapy combination cohorts and initiating additional ADC studies in multiple solid tumors.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:13 PM ET
Data refreshes hourly during market hours. Next update: 3:13 PM
Data refreshes hourly during market hours. Next update: 3:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CBIO Research Pages